Cargando…
Recent advances in immune checkpoint inhibitors for non-small lung cancer treatment
Lung cancer is one of the deadliest types of cancer responsible for thousands of cancer-related deaths. Its treatment has remained a challenge for researchers, but an increase in the knowledge of molecular pathways and biology of lung cancer has dramatically changed its management in recent decades....
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552217/ https://www.ncbi.nlm.nih.gov/pubmed/36237320 http://dx.doi.org/10.3389/fonc.2022.1014156 |